Efficacy of combination products containing sarolaner, moxidectin and pyrantel (Simparica Trio™) or afoxolaner and milbemycin (NexGard Spectra®) against induced infestations of Ixodes holocyclus in dogs
Abstract Background The Australian paralysis tick, Ixodes holocyclus, causes tick paralysis in dogs and cats in the eastern coastal regions of Australia. Prevention is the best option to protect dogs against this potentially fatal disease and sarolaner provides rapid and sustained efficacy against I...
Main Authors: | Raj Packianathan, Andrew Hodge, Natalie Bruellke, Chrissie Jackson, Steven Maeder |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-09-01
|
Series: | Parasites & Vectors |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13071-020-04323-8 |
Similar Items
-
Efficacy of two formulations of afoxolaner (NexGard® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in Europe
by: Wilfried Lebon, et al.
Published: (2018-09-01) -
Assessment of the insecticidal activity of afoxolaner against Aedes aegypti in dogs treated with NexGard®
by: Liebenberg Julian, et al.
Published: (2017-01-01) -
Efficacy of afoxolaner (NexGard®) in preventing the transmission of Leishmania infantum and Dirofilaria immitis to sheltered dogs in a highly endemic area
by: Rossella Panarese, et al.
Published: (2021-07-01) -
Field safety and efficacy of an orally administered combination of sarolaner, moxidectin and pyrantel (Simparica Trio®) for the prevention of angiostrongylosis in dogs presented as veterinary patients
by: Csilla Becskei, et al.
Published: (2020-07-01) -
Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis
by: Beugnet Frédéric, et al.
Published: (2016-01-01)